Abstract: A holder for a floating balloon having a variety of protrusions or holes form to or through which a floating balloon can be tied, and a slit to allow a first end and a second and to be separated apart so that the holder can be attached to a variety of objects or human body parts.

Abstract: The present invention is directed to the detection and quantification of total ras p21 in body fluids, particularly serial changes of total ras p21 levels in a subject's body fluids. Further, the invention is directed to detecting and quantitating total ras p21 in conjunction with one or more other proteins, such as, oncoproteins, angiogenic factors, tumor markers, inhibitors, growth factor receptors, metastasis proteins, and tumor suppressors. The disclosed methods are diagnostic/prognostic for preneoplastic/neoplastic diseases, and useful to select therapies for patients with preneoplastic/neoplastic diseases. The disclosed methods are further useful to monitor the status of a patient's preneoplastic/neoplastic disease, and/or to monitor how a patient is responding to an anticancer therapy.

Abstract: A holder for a floating balloon having a variety of protrusions or holes form to or through which a floating balloon can be tied, and a slit to allow a first end and a second and to be separated apart so that the holder can be attached to a variety of objects or human body parts.

Abstract: The present invention is directed to the detection and quantification of total ras p21 in body fluids, particularly serial changes of total ras p21 levels in a subject's body fluids. Further, the invention is directed to detecting and quantitatiing total ras p21 in conjunction with one or more other proteins, such as, oncoproteins, angiogenic factors, tumor markers, inhibitors, growth factor receptors, metastasis proteins, and tumor suppressors. The disclosed methods are diagnostic/prognostic for preneoplastic/neoplastic diseases, and useful to select therapies for patients with preneoplastic/neoplastic diseases. The disclosed methods are further useful to monitor the status of a patient's preneoplastic/neoplastic disease, and/or to monitor how a patient is responding to an anticancer therapy.

Abstract: An otherwise conventional powdered alginate impression material is improved by the admixture of flavoring in powdered form, rather than liquid form. By utilizing a powdered flavoring, rather than a liquid flavoring, the components of the dental impression material can remain totally in powdered form until mixed with water in an orthodontic office immediately prior to taking a dental impression. By providing the flavoring for the powdered alginate material in powdered form, the shipment of any component of the alginate impression material in liquid form is avoided. As a consequence, the powdered flavoring material for the alginate impression composition is not susceptible to liquid leakage and does not create a disagreeable, sticky mess even if the container is broken during shipment.

Abstract: Embodiments of a fluid system and of methods of operation of a fluid system are disclosed. In one embodiment, the fluid system comprises at least one source of fluid, a nozzle and at least one first valve fluidly connecting the nozzle with the at least one source of fluid. The at least one first valve is movable between a first position where fluid flows between the at least one source of fluid and the nozzle, and a second position where fluid does not flow between the at least one source of fluid and the nozzle. A waste receptacle and at least one second valve fluidly connecting the waste receptacle with the at least one source of fluid are included. The at least one second valve is fluidly connected between the at least one source of fluid and the at least one first valve.